New Medicare drug price cap starts January 1, 2025, limiting out-of-pocket costs to $2,000 annually for beneficiaries under the Inflation Reduction Act.
As the restaurant industry faces multiple challenges in 2025, key issues include rising labor costs, supply chain disruptions, and competition from delivery apps.
Trump's proposed tariffs may raise drug prices and cause shortages, impacting the U.S. pharmaceutical market by increasing the cost and availability of medications.